HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert O Messing Selected Research

Protein Kinase C-epsilon

3/2016Binge Drinking With Protein Kinase C Epsilon: A Role for Mammalian Target of Rapamycin Complex 2?
7/2006Ethanol withdrawal induces hyperalgesia mediated by PKCepsilon.
9/2005Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning.
2/2005Protein kinase C isozymes in stroke.
1/2004Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase C epsilon.
6/2002Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert O Messing Research Topics

Disease

15Alcoholism (Alcohol Abuse)
01/2022 - 11/2002
6Ataxia (Dyssynergia)
01/2021 - 11/2004
5Binge Drinking
12/2017 - 01/2008
3Alcoholic Neuropathy (Alcoholic Polyneuropathy)
01/2014 - 07/2006
3Hyperalgesia
04/2012 - 07/2006
3Ischemia
07/2004 - 06/2002
2Pain (Aches)
10/2021 - 01/2016
2Substance-Related Disorders (Drug Abuse)
10/2008 - 04/2004
2Peripheral Nervous System Diseases (PNS Diseases)
09/2008 - 01/2008
2Stroke (Strokes)
02/2005 - 07/2004
2Reperfusion Injury
02/2005 - 07/2004
1Opioid-Related Disorders (Opiate Addiction)
01/2022
1Migraine Disorders (Migraine)
10/2021
1Headache (Headaches)
10/2021
1Atopic Dermatitis (Atopic Eczema)
01/2021
1Inflammation (Inflammations)
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018
1Central Nervous System Diseases (CNS Diseases)
01/2018
1Neoplasms (Cancer)
07/2011
1Cerebral Infarction
02/2011
1Mental Disorders (Mental Disorder)
10/2010
1Albuminuria
07/2010
1Chronic Hepatitis C
04/2009
1Virus Diseases (Viral Diseases)
04/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
09/2008
1Neuralgia (Stump Neuralgia)
09/2008

Drug/Important Bio-Agent (IBA)

10Ethanol (Ethyl Alcohol)IBA
01/2022 - 11/2004
6Protein Kinase CIBA
10/2021 - 06/2002
6Protein Kinase C-epsilonIBA
03/2016 - 06/2002
5Pharmaceutical PreparationsIBA
12/2019 - 10/2008
4Protein Kinases (Protein Kinase)IBA
10/2021 - 07/2004
4Peptides (Polypeptides)IBA
10/2021 - 02/2005
3Hypnotics and Sedatives (Sedatives)IBA
01/2021 - 11/2004
3apremilastIBA
11/2020 - 01/2018
3IsoenzymesIBA
05/2006 - 04/2004
2Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2022 - 01/2008
2Mifepristone (RU 486)FDA Link
01/2022 - 01/2008
2Protein Isoforms (Isoforms)IBA
10/2021 - 06/2002
2gaboxadol (THIP)IBA
01/2021 - 11/2020
2Diazepam (Valium)FDA LinkGeneric
01/2021 - 11/2020
2Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
12/2017 - 10/2013
2CRF receptor type 1IBA
12/2017 - 10/2013
2EnzymesIBA
04/2012 - 07/2004
1RNA (Ribonucleic Acid)IBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1Biological ProductsIBA
01/2022
1Corticotropin-Releasing HormoneIBA
01/2022
1Sumatriptan (Imigran)FDA LinkGeneric
10/2021
1Calcitonin Gene-Related PeptideIBA
10/2021
1Topiramate (Topamax)FDA LinkGeneric
10/2021
1Nitroglycerin (Dynamite)FDA LinkGeneric
10/2021
1calcitonin gene-related peptide (8-37)IBA
10/2021
1ElementsIBA
08/2021
1CytokinesIBA
01/2021
1Imiquimod (Aldara)FDA LinkGeneric
01/2021
1EtomidateFDA LinkGeneric
11/2020
1Zolpidem (Ambien)FDA LinkGeneric
11/2020
1protein kinase modulatorIBA
11/2020
1loreclezoleIBA
11/2020
1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
11/2020
1Propofol (Diprivan)FDA LinkGeneric
11/2020
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2020
1SaccharinIBA
01/2020
13- (3- (pyridine- 3- yl)- 1,2,4- oxadiazol- 5- yl)benzonitrileIBA
01/2020
1Complement System Proteins (Complement)IBA
12/2019
1EmeticsIBA
01/2018
1Phosphodiesterase 4 InhibitorsIBA
01/2018
1TOR Serine-Threonine KinasesIBA
03/2016
1GlobinsIBA
01/2016
1Hemoglobins (Hemoglobin)IBA
01/2016
1Quinine (Quinson)FDA Link
09/2015
1Serine (L-Serine)FDA Link
09/2015
1VitaminsIBA
01/2014
1Vitamin B Complex (B Vitamins)IBA
01/2014
1Levetiracetam (Keppra)FDA LinkGeneric
04/2012
1Sodium Channels (Sodium Channel)IBA
04/2012
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2012
1Cisplatin (Platino)FDA LinkGeneric
07/2011
1Coloring Agents (Dyes)IBA
02/2011
1triphenyltetrazoliumIBA
02/2011
1GABA-A Receptors (GABA(A) Receptor)IBA
10/2010
1Cytochromes c (Cytochrome c)IBA
07/2010
1AlbuminsIBA
07/2010
1NucleosidesIBA
04/2009
1Ribavirin (Virazole)FDA LinkGeneric
04/2009
1N-Type Calcium Channels (N-Type Calcium Channel)IBA
03/2009
1Pentobarbital (Nembutal)FDA Link
11/2008
1Pregnanolone (Allopregnanolone)IBA
11/2008
1GABA-A Receptor AgonistsIBA
11/2008
1Phosphotransferases (Kinase)IBA
10/2008
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
09/2008
1Monoamine Oxidase (MAO)IBA
09/2008
1CatecholaminesIBA
09/2008
13,4-dihydroxyphenylglycolaldehydeIBA
09/2008
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
09/2008

Therapy/Procedure

3Therapeutics
07/2011 - 11/2002
2Drug Therapy (Chemotherapy)
07/2011 - 10/2008
1Self Administration (Administration, Self)
10/2008
1Intradermal Injections
09/2008